(MedPage Today) — Wide-scale disclosure of clinical errors seems intuitively to be the ethical choice for hospitals and physicians, but researchers from the University of Washington suggest that disclosure should be decided on a case-by-case basis rather than a one-size-fits-all solution
No Comments »
Filed under: General Health News
(MedPage Today) — Older veterans with a history of post-traumatic stress disorder (PTSD) are at increased risk for developing dementia, even if they had not been wounded in battle, researchers found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — This year workers paid 14% more for their employer-sponsored healthcare coverage than they did last year as a bigger chunk of healthcare costs shifted from employers to employees, according to a new survey.
No Comments »
Filed under: General Health News
(MedPage Today) — Nearly half of all Americans — 48% — took at least one prescription drug in a one-month period in 2007-2008, a four percentage point hike over a decade, researchers found.
No Comments »
Filed under: General Health News
(MedPage Today) — A warning that the intravenous antibiotic drug tigecycline (Tygacil) is associated with increased risk of death, compared with other antibiotics, will be added to the product’s label, the FDA said.
No Comments »
Filed under: Pharmacy News
As the summer comes to a close, I wanted to update you on the Company’s accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges [...]
No Comments »
Filed under: Pharmacy News
Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions
No Comments »
Filed under: Pharmacy News
Oncolytics Biotech Inc. announced today that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN(R) in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
No Comments »
Filed under: Pharmacy News
Gilead Sciences, Inc. today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for marketing approval for the fixed-dose combination of Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)) and Tibotec Pharmaceuticals’ investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine (as hydrochloride)) for the treatment of HIV-1 infection in adults.
No Comments »
Filed under: Pharmacy News
Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 [...]
No Comments »
Filed under: Pharmacy News
